Business Context and Reporting Period
CareCloud, Inc. (CCLD) is a healthcare information technology company providing technology-enabled revenue cycle management (RCM), cloud-based software, and medical practice management services. This summary covers the quarterly period ended June 30, 2026 (Q2 2026), as reported in Form 10-Q. The company operates two reportable segments: Healthcare IT and Medical Practice Management.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | YTD 2026 (6 Months) | Q2 2025 (3 Months) | YTD 2025 (6 Months) |
|---|---|---|---|---|
| Net Revenue | $31.9 million | $63.2 million | $27.4 million | $55.0 million |
| Operating Income | $1.9 million | $2.9 million | $3.0 million | $5.0 million |
| Net Income | $1.1 million | $2.0 million | $2.9 million | $4.9 million |
| Net Income Attributable to Common | $0.2 million | $(0.3) million | $1.5 million | $0.7 million |
| Adjusted EBITDA | $5.9 million | $11.3 million | $6.5 million | $12.1 million |
| Cash and Restricted Cash | $13.4 million | $13.4 million | $10.4 million | $10.4 million |
| Total Debt (Current + Long-term) | $40.0 million | $40.0 million | $1.2 million | $1.2 million |
| Operating Cash Flow (YTD) | $10.7 million | $10.7 million | $12.5 million | $12.5 million |
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased 16% year-over-year (YoY) for Q2 and 15% YoY for the six-month period, driven primarily by technology-enabled business solutions and recent acquisitions (Medsphere, Empower, MAP App).
- Profitability Decline: Operating income decreased 38% YoY in Q2 and 43% YoY YTD. This was primarily due to a significant increase in interest expense and higher operating costs.
- Debt Expansion: Total debt obligations surged from $1.2 million at year-end 2025 to $40.0 million at June 30, 2026. This reflects a new $50 million credit facility (April 2026) used to redeem Series B Preferred Stock and fund operations.
- Interest Expense Spike: Interest expense increased from $68,000 in Q2 2025 to $815,000 in Q2 2026 (a 1,099% increase) due to the new term loan and line of credit borrowings.
- Preferred Stock Redemption: The company fully redeemed all Series B Preferred Stock in May 2026, utilizing approximately $41.6 million of the new credit facility proceeds.
Guidance, Outlook, Risks, and Unusual Items
- Cybersecurity Incident: On March 16, 2026, a security incident affected one electronic health record environment, resulting in the exfiltration of patient data. The company expects costs (investigation, remediation, legal) to be covered by insurance subject to a $100,000 retention. Multiple class action complaints have been filed.
- Acquisitions: The company completed acquisitions of Empower Healthcare & Compliance Partners (May 2026), MAP App (Oct 2025), and Medsphere (Aug 2025). These contributed significantly to revenue growth but increased amortization expenses.
- Offshore Operations Risk: Approximately 17-18% of total expenses are attributed to offshore operations in Pakistan and Sri Lanka. Geopolitical instability or trade restrictions in these regions pose a material risk to cost structures and service delivery.
- Liquidity: Management forecasts sufficient liquidity to meet obligations for the next 12 months. The company maintains an At-The-Market (ATM) equity offering agreement for up to $60 million, though no sales have occurred yet.
- AI Integration: The company is actively integrating AI solutions (cirrusAI, stratusAI) to enhance clinical decision support and automate workflows, though this has increased R&D expenses.
Investor Verification Checklist
- Debt Covenants: Verify compliance with the new Citizens Bank/Provident credit facility covenants, given the significant increase in leverage.
- Cybersecurity Costs: Monitor actual out-of-pocket costs related to the March 2026 data breach and the status of insurance claims.
- Preferred Stock Dividends: Confirm the ongoing cash outflow for Series A Preferred Stock dividends (approx. $1.1 million/month) and the impact on net income attributable to common shareholders.
- Acquisition Integration: Assess the realization of synergies and revenue retention from the Medsphere, Empower, and MAP App acquisitions.
- Offshore Exposure: Evaluate the stability of operations in Pakistan and Sri Lanka and potential cost impacts from geopolitical shifts.